Laboratory Products
Expanded Drug Discovery Collaboration
Jan 22 2010
BioFocus DPI announced that it has initiated a drug discovery collaboration with Schering-Plough Research Institute (SPRI). Under the terms of the agreement, BioFocus DPI will perform medicinal chemistry with supporting biology and ADME/PK services for multiple Schering-Plough drug discovery projects. Total contract value for BioFocus DPI is €2.8 million over a one year period.
Building on a collaboration established in May 2009 and expanded in September 2009, BioFocus DPI scientists will work with two of SPRI’s European sites on these drug discovery projects.
“We are pleased to build on our collaborative relationship with SPRI, which has evolved into one of the larger for BioFocus DPI this year with over 20 research staff currently engaged,” said Onno van de Stolpe, CEO of Galapagos. “BioFocus DPI has proven resilient in securing large collaborations with strong partners, amidst consolidation and reorganisation in the pharma industry.”
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark